Roivant Sciences Ltd. (ROIV) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
Roivant Sciences Ltd. (ROIV) Profile & Business Summary
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Key Information
| Ticker | ROIV |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://roivant.com |
Market Trend Overview for ROIV
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-14 (ET)
As of 2026-07-14, ROIV is moving sideways without a clear direction. Over the longer term, the trend remains bullish.
ROIV last closed at 34.91. The price is about 0.9 ATR below its recent average price (35.87), and the market is currently in a sideways market without a clear direction. Price at 34.91 is moving between minor support near 33.15 and minor resistance near 35.90. Direction remains unclear. View Support & Resistance from Options
The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.
Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 30.08. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-06-15, reflecting a technical shift toward positive directional alignment.
[2026-06-03] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
There was no clear sign of meaningful positions being carried into the overnight session.
The model stays neutral because the setup is not clear enough to justify a directional deployment.
The model does not deploy this setup because recent price behavior has shown failed reversal memory. Predictability is 37%, agreement is 65%, and reversal risk is 14%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is only slightly above the recent estimated cost basis of 34.57. The main cost band sits between 34.35 and 35.38. The lower down support area sits around 33.91 to 34.23. It looks more like a first buffer than a major floor. The higher up selling area sits around 35.26 to 35.94, so rebounds may begin to slow as price pushes into that zone. Recent positioning looks fairly balanced, with 50% in profit and 50% under water. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the structure is still best read by comparing price with the main cost band first, then watching whether the lower support zone or higher supply zone becomes the next directional checkpoint.